Karen Miotto

University of California, Los Angeles — United States

Medicine · Health Sciences

36h-index5.5kcitations98works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Substance Abuse Treatment and Outcomes(30), Opioid Use Disorder Treatment(25), Neurotransmitter Receptor Influence on Behavior(20), Healthcare professionals’ stress and burnout(7), Nicotinic Acetylcholine Receptors Study(7)

Publications98 total

Suvorexant for alcohol use disorder and post-traumatic stress disorder: study protocol for a phase II randomized clinical trial
Trials·2026Open Access
Assessing buprenorphine treatment utilization and SAMHSA DATA waiver provider distribution in 2021: a real-world analysis in California
Scientific Reports·2025Open Access
Professional Coaching to Reduce Physician Burnout: A Randomized Clinical Trial
Journal of General Internal Medicine·2025· 2 citedOpen Access
Inflammatory endotoxin challenge in individuals with alcohol use disorder and controls
Alcohol Clinical and Experimental Research·2025· 3 cited
A Neuroimmune Modulator for Alcohol Use Disorder
JAMA Network Open·2025· 11 citedOpen Access
Effects of a novel <scp>GABA</scp>‐B positive allosteric modulator, <scp>ASP8062</scp>, on alcohol cue‐elicited craving and naturalistic alcohol consumption in a multisite randomized, double‐blind, placebo‐controlled trial
Alcohol Clinical and Experimental Research·2024· 3 citedOpen Access
Change of opioid prescribing before and after the COVID pandemic in California, 2017-2022
2024Open Access
Does sex moderate the effects of early life stress on peripheral inflammation in alcohol use disorder? A preliminary investigation
Drug and Alcohol Dependence·2024· 3 citedOpen Access
Measurement Bias in Machine Learning-Enhanced Opioid Risk Scoring Systems
2024Open Access
Assessing Buprenorphine Treatment Utilization and SAMHSA DATA Waiver Provider Distribution in 2021: A Real-World Analysis in California
2024Open Access
A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial
Psychopharmacology·2023· 7 citedOpen Access
Before and During the First COVID-19 Surge: Work Conditions, Burnout, and Mental Health Among Resident Physicians in a Department of Psychiatry in the USA
Academic Psychiatry·2023· 4 citedOpen Access
Alcohol Use Among Treatment-Seeking Individuals with Opioid Use Disorder
Journal of Studies on Alcohol and Drugs·2023· 2 citedOpen Access
Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study
The American Journal of Drug and Alcohol Abuse·2022· 19 citedOpen Access
Effects of ibudilast on central and peripheral markers of inflammation in alcohol use disorder: A randomized clinical trial
Addiction Biology·2022· 25 citedOpen Access
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Drugs·2022· 150 citedOpen Access
Combined varenicline and naltrexone attenuates alcohol cue-elicited activation in heavy drinking smokers
Drug and Alcohol Dependence·2021· 8 citedOpen Access
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial
Translational Psychiatry·2021· 80 citedOpen Access
Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
American Journal of Psychiatry·2021· 36 citedOpen Access
Ibudilast moderates the effect of mood on alcohol craving during stress exposure.
Experimental and Clinical Psychopharmacology·2021· 10 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Lara A. Ray(18), Richard A. Rawson(9), Walter Ling(9), Spencer Bujarski(9), Edythe D. London(7), Steven Shoptaw(6), Erica N. Grodin(6), Michael McCann(5), Daniel Roche(5), Andrew J. Saxon(4), Elizabeth M. Burnette(4), Steven J. Nieto(4), Lindsay R. Meredith(4), Aaron C. Lim(4), Kelly E. Courtney(4), Jesse Sanford(4), Yih‐Ing Hser(3), Larissa J. Mooney(3), Douglas S. Bell(3), David Huang(3)